Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...
Moderna Inc. MRNA edged up 0.58%, while Pfizer Inc. PFE gained 2.95% amid heightened focus on potential bird flu preparedness. CDC official John Nkengasong‘s Sunday memo, viewed by The ...
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as it aims to show investors steadier execution and growth after large swings ...
"Pfizer just released its list of side effects of its COVID-19 vaccine," multiple Facebook posts said Jan. 26 and 27. The posts included a purported list of 46 Pfizer-BioNtech COVID-19 vaccine side ...
The Make America Healthy Again commission is taking action on mRNA vaccines as several states consider legislation to ban ...
The NHS uses vaccines from two companies across the UK: Pfizer-BioNTech and Moderna. People are advised to take whichever vaccine they are offered, as both provide protection against severe ...